A Biovectra manufacturing facility (Photo: Business Wire)
July 22, 2024 12:29 PM EDT
Deals
Manufacturing

Ag­i­lent Tech­nolo­gies to ac­quire CD­MO Biovec­tra for $925M

Katherine Lewin

News Reporter

Ag­i­lent Tech­nolo­gies plans to buy Cana­di­an CD­MO Biovec­tra in a $925 mil­lion deal, which Ag­i­lent says will deep­en its fo­cus on oligonu­cleotides and CRISPR. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times